# Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer

> **NCT07271823** · — · ACTIVE_NOT_RECRUITING · sponsor: **Zhejiang Cancer Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Pancreatic Cancer Non-resectable

## Interventions

- **OTHER:** Sample Collection

## Key facts

- **NCT ID:** NCT07271823
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07271823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07271823, "Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07271823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*